Health and safety code section 11053-11058




CALIFORNIA CODES



HEALTH AND SAFETY CODE



SECTION 11053-11058



















11053.  The controlled substances listed or to be listed in the



schedules in this chapter are included by whatever official, common,



usual, chemical, or trade name designated.















11054.  (a) The controlled substances listed in this section are



included in Schedule I.



   (b) Opiates.  Unless specifically excepted or unless listed in



another schedule, any of the following opiates, including their



isomers, esters, ethers, salts, and salts of isomers, esters, and



ethers whenever the existence of those isomers, esters, ethers, and



salts is possible within the specific chemical designation:



   (1) Acetylmethadol.



   (2) Allylprodine.



   (3) Alphacetylmethadol (except levoalphacetylmethadol, also known



as levo-alpha- acetylmethadol, levomethadyl acetate, or LAAM).



   (4) Alphameprodine.



   (5) Alphamethadol.



   (6) Benzethidine.



   (7) Betacetylmethadol.



   (8) Betameprodine.



   (9) Betamethadol.



   (10) Betaprodine.



   (11) Clonitazene.



   (12) Dextromoramide.



   (13) Diampromide.



   (14) Diethylthiambutene.



   (15) Difenoxin.



   (16) Dimenoxadol.



   (17) Dimepheptanol.



   (18) Dimethylthiambutene.



   (19) Dioxaphetyl butyrate.



   (20) Dipipanone.



   (21) Ethylmethylthiambutene.



   (22) Etonitazene.



   (23) Etoxeridine.



   (24) Furethidine.



   (25) Hydroxypethidine.



   (26) Ketobemidone.



   (27) Levomoramide.



   (28) Levophenacylmorphan.



   (29) Morpheridine.



   (30) Noracymethadol.



   (31) Norlevorphanol.



   (32) Normethadone.



   (33) Norpipanone.



   (34) Phenadoxone.



   (35) Phenampromide.



   (36) Phenomorphan.



   (37) Phenoperidine.



   (38) Piritramide.



   (39) Proheptazine.



   (40) Properidine.



   (41) Propiram.



   (42) Racemoramide.



   (43) Tilidine.



   (44) Trimeperidine.



   (45) Any substance which contains any quantity of acetylfentanyl



(N-(1-phenethyl-4-piperidinyl) acetanilide) or a derivative thereof.







   (46) Any substance which contains any quantity of the thiophene



analog of acetylfentanyl (N-(1-(2-(2-thienyl)ethyl)-4-piperidinyl)



acetanilide) or a derivative thereof.



   (47) 1-Methyl-4-Phenyl-4-Propionoxypiperidine (MPPP).



   (48) 1-(2-Phenethyl)-4-Phenyl-4-Acetyloxypiperidine (PEPAP).



   (c) Opium derivatives.  Unless specifically excepted or unless



listed in another schedule, any of the following opium derivatives,



its salts, isomers, and salts of isomers whenever the existence of



those salts, isomers, and salts of isomers is possible within the



specific chemical designation:



   (1) Acetorphine.



   (2) Acetyldihydrocodeine.



   (3) Benzylmorphine.



   (4) Codeine methylbromide.



   (5) Codeine-N-Oxide.



   (6) Cyprenorphine.



   (7) Desomorphine.



   (8) Dihydromorphine.



   (9) Drotebanol.



   (10) Etorphine (except hydrochloride salt).



   (11) Heroin.



   (12) Hydromorphinol.



   (13) Methyldesorphine.



   (14) Methyldihydromorphine.



   (15) Morphine methylbromide.



   (16) Morphine methylsulfonate.



   (17) Morphine-N-Oxide.



   (18) Myrophine.



   (19) Nicocodeine.



   (20) Nicomorphine.



   (21) Normorphine.



   (22) Pholcodine.



   (23) Thebacon.



   (d) Hallucinogenic substances.  Unless specifically excepted or



unless listed in another schedule, any material, compound, mixture,



or preparation, which contains any quantity of the following



hallucinogenic substances, or which contains any of its salts,



isomers, and salts of isomers whenever the existence of those salts,



isomers, and salts of isomers is possible within the specific



chemical designation (for purposes of this subdivision only, the term



"isomer" includes the optical, position, and geometric isomers):



   (1)  4-bromo-2,5-dimethoxy-amphetamine--Some trade or other names:



  4-bromo-2,5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2,5-DMA.







   (2) 2,5-dimethoxyamphetamine--Some trade or other names:



2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA.



   (3) 4-methoxyamphetamine--Some trade or other names:



4-methoxy-alpha-methylphenethylamine, paramethoxyamphetamine, PMA.



   (4) 5-methoxy-3,4-methylenedioxy-amphetamine.



   (5) 4-methyl-2,5-dimethoxy-amphetamine--Some trade or other names:



  4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; "DOM"; and "STP."







   (6) 3,4-methylenedioxy amphetamine.



   (7) 3,4,5-trimethoxy amphetamine.



   (8) Bufotenine--Some trade or other names:  3-



(beta-dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5



indolol; N,N-dimethylserolonin, 5-hydroxy-N,N-dimethyltryptamine;



mappine.



   (9) Diethyltryptamine--Some trade or other names:



N,N-Diethyltryptamine; DET.



   (10) Dimethyltryptamine--Some trade or other names:  DMT.



   (11) Ibogaine--Some trade or other names:  7-Ethyl-6,6beta,



7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido (1',2':1,2)



azepino (5,4-b) indole; Tabernantheiboga.



   (12) Lysergic acid diethylamide.



   (13) Marijuana.



   (14) Mescaline.



   (15) Peyote--Meaning all parts of the plant presently classified



botanically as Lophophora williamsii Lemaire, whether growing or not,



the seeds thereof, any extract from any part of such plant, and



every compound, manufacture, salts, derivative, mixture, or



preparation of such plant, its seeds or extracts (interprets 21



U.S.C. Sec. 812(c), Schedule 1(c)(12)).



   (16) N-ethyl-3-piperidyl benzilate.



   (17) N-methyl-3-piperidyl benzilate.



   (18) Psilocybin.



   (19) Psilocyn.



   (20) Tetrahydrocannabinols.  Synthetic equivalents of the



substances contained in the plant, or in the resinous extractives of



Cannabis, sp. and/or synthetic substances, derivatives, and their



isomers with similar chemical structure and pharmacological activity



such as the following:  delta 1 cis or trans tetrahydrocannabinol,



and their optical isomers; delta 6 cis or trans tetrahydrocannabinol,



and their optical isomers; delta 3,4 cis or trans



tetrahydrocannabinol, and its optical isomers.



   (Since nomenclature of these substances is not internationally



standardized, compounds of these structures, regardless of numerical



designation of atomic positions covered).



   (21) Ethylamine analog of phencyclidine--Some trade or other



names:  N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)



ethylamine, N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE.



   (22) Pyrrolidine analog of phencyclidine--Some trade or other



names:  1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP.



   (23) Thiophene analog  of phencyclidine--Some trade or other



names:  1-(1-(2 thienyl)-cyclohexyl)-piperidine, 2-thienyl analog of



phencyclidine, TPCP, TCP.



   (e) Depressants.  Unless specifically excepted or unless listed in



another schedule, any material, compound, mixture, or preparation



which contains any quantity of the following substances having a



depressant effect on the central nervous system, including its salts,



isomers, and salts of isomers whenever the existence of those salts,



isomers, and salts of isomers is possible within the specific



chemical designation:



   (1) Mecloqualone.



   (2) Methaqualone.



   (f) Unless specifically excepted or unless listed in another



schedule, any material, compound, mixture, or preparation which



contains any quantity of the following substances having a stimulant



effect on the central nervous system, including its isomers:



   (1) Cocaine base.



   (2) Fenethylline, including its salts.



   (3) N-Ethylamphetamine, including its salts.















11055.  (a) The controlled substances listed in this section are



included in Schedule II.



   (b) Any of the following substances, except those narcotic drugs



listed in other schedules, whether produced directly or indirectly by



extraction from substances of vegetable origin, or independently by



means of chemical synthesis, or by combination of extraction and



chemical synthesis:



   (1) Opium, opiate, and any salt, compound, derivative, or



preparation of opium or opiate, with the exception of naloxone



hydrochloride (N-allyl-14-hydroxy-nordihydromorphinone



hydrochloride), but including the following:



   (A) Raw opium.



   (B) Opium extracts.



   (C) Opium fluid extracts.



   (D) Powdered opium.



   (E) Granulated opium.



   (F) Tincture of opium.



   (G) Apomorphine.



   (H) Codeine.



   (I) Ethylmorphine.



   (J) Hydrocodone.



   (K) Hydromorphone.



   (L) Metopon.



   (M) Morphine.



   (N) Oxycodone.



   (O) Oxymorphone.



   (P) Thebaine.



   (2) Any salt, compound, isomer, or derivative, whether natural or



synthetic, of the substances referred to in paragraph (1), but not



including the isoquinoline alkaloids of opium.



   (3) Opium poppy and poppy straw.



   (4) Coca leaves and any salt, compound, derivative, or preparation



of coca leaves, but not including decocainized coca leaves or



extractions which do not contain cocaine or ecgonine.



   (5) Concentrate of poppy straw (the crude extract of poppy straw



in either liquid, solid, or powder form which contains the



phenanthrene alkaloids of the opium poppy).



   (6) Cocaine, except as specified in Section 11054.



   (7) Ecgonine, whether natural or synthetic, or any salt, isomer,



derivative, or preparation thereof.



   (c) Opiates.  Unless specifically excepted or unless in another



schedule, any of the following opiates, including its isomers,



esters, ethers, salts, and salts of isomers, esters, and ethers



whenever the existence of those isomers, esters, ethers, and salts is



possible within the specific chemical designation, dextrorphan and



levopropoxyphene excepted:



   (1) Alfentanyl.



   (2) Alphaprodine.



   (3) Anileridine.



   (4) Bezitramide.



   (5) Bulk dextropropoxyphene (nondosage forms).



   (6) Dihydrocodeine.



   (7) Diphenoxylate.



   (8) Fentanyl.



   (9) Isomethadone.



   (10) Levoalphacetylmethadol, also known as



levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM.  This



substance is authorized for the treatment of narcotic addicts under



federal law (see Part 291 (commencing with Section 291.501) and Part



1308 (commencing with Section 1308.01) of Title 21 of the Code of



Federal Regulations).



   (11) Levomethorphan.



   (12) Levorphanol.



   (13) Metazocine.



   (14) Methadone.



   (15) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl



butane.



   (16) Moramide-Intermediate, 2-methyl-3-morpholino-1,



1-diphenylpropane-carboxylic acid.



   (17) Pethidine (meperidine).



   (18) Pethidine-Intermediate-A,



4-cyano-1-methyl-4-phenylpiperidine.



   (19) Pethidine-Intermediate-B,



ethyl-4-phenylpiperidine-4-carboxylate.



   (20) Pethidine-Intermediate-C,



1-methyl-4-phenylpiperidine-4-carboxylic acid.



   (21) Phenazocine.



   (22) Piminodine.



   (23) Racemethorphan.



   (24) Racemorphan.



   (25) Sufentanyl.



   (d) Stimulants.  Unless specifically excepted or unless listed in



another schedule, any material, compound, mixture, or preparation



which contains any quantity of the following substances having a



stimulant effect on the central nervous system:



   (1) Amphetamine, its salts, optical isomers, and salts of its



optical isomers.



   (2) Methamphetamine, its salts, isomers, and salts of its isomers.







   (3) Dimethylamphetamine (N,N-dimethylamphetamine), its salts,



isomers, and salts of its isomers.



   (4) N-Ethylmethamphetamine (N-ethyl, N-methylamphetamine), its



salts, isomers, and salts of its isomers.



   (5) Phenmetrazine and its salts.



   (6) Methylphenidate.



   (e) Depressants.  Unless specifically excepted or unless listed in



another schedule, any material, compound, mixture, or preparation



which contains any quantity of the following substances having a



depressant effect on the central nervous system, including its salts,



isomers, and salts of isomers whenever the existence of those salts,



isomers, and salts of isomers is possible within the specific



chemical designation:



   (1) Amobarbital.



   (2) Pentobarbital.



   (3) Phencyclidines, including the following:



   (A) 1-(1-phenylcyclohexyl) piperidine (PCP).



   (B) 1-(1-phenylcyclohexyl) morpholine (PCM).



   (C) Any analog of phencyclidine which is added by the Attorney



General by regulation pursuant to this paragraph.



   The Attorney General, or his or her designee, may, by rule or



regulation, add additional analogs of phencyclidine to those



enumerated in this paragraph after notice, posting, and hearing



pursuant to Chapter 3.5 (commencing with Section 11340) of Part 1 of



Division 3 of Title 2 of the Government Code.  The Attorney General



shall, in the calendar year of the regular session of the Legislature



in which the rule or regulation is adopted, submit a draft of a



proposed bill to  each house of the Legislature which would



incorporate the analogs into this code.  No rule or regulation shall



remain in effect beyond January 1 after the calendar year of the



regular session in which the draft of the proposed bill is submitted



to each house.  However, if the draft of the proposed bill is



submitted during a recess of the Legislature exceeding 45 calendar



days, the rule or regulation  shall be effective until January 1



after the next calendar year.



   (4) Secobarbital.



   (5) Glutethimide.



   (6) Gamma-hydroxybutyrate.



   (f) Immediate precursors.  Unless specifically excepted or unless



listed in another schedule, any material, compound, mixture, or



preparation which contains any quantity of the following substances:







   (1) Immediate precursor to amphetamine and methamphetamine:



   (A) Phenylacetone.  Some trade or other names:  phenyl-2



propanone; P2P; benzyl methyl ketone; methyl benzyl ketone.



   (2) Immediate precursors to phencyclidine (PCP):



   (A) 1-phenylcyclohexylamine.



   (B) 1-piperidinocyclohexane carbonitrile (PCC).



   (g) Hallucinogenic substances.  Any of the following



hallucinogenic substances:  dronabinol (synthetic) in sesame oil and



encapsulated in a soft gelatin capsule in a drug product approved by



the federal Food and Drug Administration.















11056.  (a) The controlled substances listed in this section are



included in Schedule III.



   (b) Stimulants.  Unless specifically excepted or unless listed in



another schedule, any material, compound, mixture, or preparation



which contains any quantity of the following substances having a



stimulant effect on the central nervous system, including its salts,



isomers (whether optical, position, or geometric), and salts of those



isomers whenever the existence of those salts, isomers, and salts of



isomers is possible within the specific chemical designation:



   (1) Those compounds, mixtures, or preparations in dosage unit form



containing  any stimulant substances listed in Schedule II which



compounds, mixtures, or preparations were listed on August 25, 1971,



as excepted compounds under Section 1308.32 of Title 21 of the Code



of Federal Regulations, and any other drug of the quantitative



composition shown in that list for those drugs or which is the same



except that it contains a lesser quantity of controlled substances.



   (2) Benzphetamine.



   (3) Chlorphentermine.



   (4) Clortermine.



   (5) Mazindol.



   (6) Phendimetrazine.



   (c) Depressants.  Unless specifically excepted or unless listed in



another schedule, any material, compound, mixture, or preparation



which contains any quantity of the following substances having a



depressant effect on the central nervous system:



   (1) Any compound, mixture, or preparation containing any of the



following:



   (A) Amobarbital



   (B) Secobarbital



   (C) Pentobarbital



or any salt thereof and one or more other active medicinal



ingredients which are not listed in any schedule.



   (2) Any suppository dosage form containing any of the following:



   (A) Amobarbital



   (B) Secobarbital



   (C) Pentobarbital



or any salt of any of these drugs and approved by the federal Food



and Drug Administration for marketing only as a suppository.



   (3) Any substance which contains any quantity of a derivative of



barbituric acid or any salt thereof.



   (4) Chlorhexadol.



   (5) Lysergic acid.



   (6) Lysergic acid amide.



   (7) Methyprylon.



   (8) Sulfondiethylmethane.



   (9) Sulfonethylmethane.



   (10) Sulfonmethane.



   (d) Nalorphine.



   (e) Narcotic drugs.  Unless specifically excepted or unless listed



in another schedule, any material, compound, mixture, or preparation



containing any of the following narcotic drugs, or their salts



calculated as the free anhydrous base or alkaloid, in limited



quantities as set forth below:



   (1) Not more than 1.8 grams of codeine per 100 milliliters or not



more than 90 milligrams per dosage unit, with an equal or greater



quantity of an isoquinoline alkaloid of opium.



   (2) Not more than 1.8 grams of codeine per 100 milliliters or not



more than 90 milligrams per dosage unit, with one or more active,



nonnarcotic ingredients in recognized therapeutic amounts.



   (3) Not more than 300 milligrams of dihydrocodeinone per 100



milliliters or not more than 15 milligrams per dosage unit, with a



fourfold or greater quantity of an isoquinoline alkaloid of opium.



   (4) Not more than 300 milligrams of dihydrocodeinone per 100



milliliters or not more than 15 milligrams per dosage unit, with one



or more active nonnarcotic ingredients in recognized therapeutic



amounts.  Additionally, oral liquid preparations of dihydrocodeinone



containing the above specified amounts may not contain as its



nonnarcotic ingredients two or more antihistamines in combination



with each other.



   (5) Not more than 1.8 grams of dihydrocodeine per 100 milliliters



or not more than 90 milligrams per dosage unit, with one or more



active nonnarcotic ingredients in recognized therapeutic amounts.



   (6) Not more than 300 milligrams of ethylmorphine per 100



milliliters or not more than 15 milligrams per dosage unit, with one



or more active, nonnarcotic ingredients in recognized therapeutic



amounts.



   (7) Not more than 500 milligrams of opium per 100 milliliters or



per 100 grams or not more than 25 milligrams per dosage unit, with



one or more active, nonnarcotic ingredients in recognized therapeutic



amounts.



   (8) Not more than 50 milligrams of morphine per 100 milliliters or



per 100 grams, with one or more active, nonnarcotic ingredients in



recognized therapeutic amounts.



   (f) Anabolic steroids and chorionic gonadotropin.  Any material,



compound, mixture, or preparation containing chorionic gonadotropin



or an anabolic steroid (excluding anabolic steroid products listed in



the "Table of Exempt Anabolic Steroid Products" (Section 1308.34 of



Title 21 of the Code of Federal Regulations), as exempt from the



federal Controlled Substances Act (Section 801 and following of Title



21 of the United States Code)), including, but not limited to, the



following:



   (1) Androisoxazole.



   (2) Androstenediol.



   (3) Bolandiol.



   (4) Bolasterone.



   (5) Boldenone.



   (6) Chlormethandienone.



   (7) Clostebol.



   (8) Dihydromesterone.



   (9) Ethylestrenol.



   (10) Fluoxymesterone.



   (11) Formyldienolone.



   (12) 4-Hydroxy-19-nortestosterone.



   (13) Mesterolone.



   (14) Methandriol.



   (15) Methandrostenolone.



   (16) Methenolone.



   (17) 17-Methyltestosterone.



   (18) Methyltrienolone.



   (19) Nandrolone.



   (20) Norbolethone.



   (21) Norethandrolone.



   (22) Normethandrolone.



   (23) Oxandrolone.



   (24) Oxymestrone.



   (25) Oxymetholone.



   (26) Quinbolone.



   (27) Stanolone.



   (28) Stanozolol.



   (29) Stenbolone.



   (30) Testosterone.



   (31) Trenbolone.



   (32) Chorionic Gonadotropin (HGC).



   (g) Ketamine.  Any material, compound, mixture, or preparation



containing ketamine.















11057.  (a) The controlled substances listed in this section are



included in Schedule IV.



   (b) Schedule IV shall consist of the drugs and other substances,



by whatever official name, common or usual name, chemical name, or



brand name designated, listed in this section.



   (c) Narcotic drugs.  Unless specifically excepted or unless listed



in another schedule, any material, compound, mixture, or preparation



containing any of the following narcotic drugs, or their salts



calculated as the free anhydrous base or alkaloid, in limited



quantities as set forth below:



   (1) Not more than 1 milligram of difenoxin and not less than 25



micrograms of atropine sulfate per dosage unit.



   (2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,



2-diphenyl-3-methyl-2-propionoxybutane).



   (d) Depressants.  Unless specifically excepted or unless listed in



another schedule, any material, compound, mixture, or preparation



which contains any quantity of the following substances, including



its salts, isomers, and salts of isomers whenever the existence of



those salts, isomers, and salts of isomers is possible within the



specific chemical designation:



   (1) Alprazolam.



   (2) Barbital.



   (3) Chloral betaine.



   (4) Chloral hydrate.



   (5) Chlordiazepoxide.



   (6) Clonazepam.



   (7) Clorazepate.



   (8) Diazepam.



   (9) Ethchlorvynol.



   (10) Ethinamate.



   (11) Flunitrazepam.



   (12) Flurazepam.



   (13) Lorazepam.



   (14) Mebutamate.



   (15) Meprobamate.



   (16) Methohexital.



   (17) Methylphenobarbital (Mephobarbital).



   (18) Oxazepam.



   (19) Paraldehyde.



   (20) Petrichoral.



   (21) Phenobarbital.



   (22) Prazepam.



   (23) Quazepam.



   (24) Temazepam.



   (25) Triazolam.



   (e) Fenfluramine.  Any material, compound, mixture, or preparation



which contains any quantity of the following substances, including



its salts, isomers (whether optical, position, or geometric), and



salts of those isomers, whenever the existence of those salts,



isomers, and salts of isomers is possible:



   (1) Fenfluramine.



   (f) Stimulants.  Unless specifically excepted or unless listed in



another schedule, any material, compound, mixture, or preparation



which contains any quantity of the following substances having a



stimulant effect on the central nervous system, including its salts,



isomers (whether optical, position, or geometric), and salts of those



isomers is possible within the specific chemical designation:



   (1) Diethylpropion.



   (2) Phentermine.



   (3) Pemoline (including organometallic complexes and chelates



thereof).



   (4) Pipradrol.



   (5) SPA ((-)-1-dimethylamino-1,2-diphenylethane).



   (g) Other substances.  Unless specifically excepted or unless



listed in another schedule, any material, compound, mixture or



preparation which contains any quantity of pentazocine, including its



salts.















11058.  (a) The controlled substances listed in this section are



included in Schedule V.



   (b) Schedule V shall consist of the drugs and other substances, by



whatever official name, common or usual name, chemical name, or



brand name designated, listed in this section.



   (c) Narcotic drugs containing nonnarcotic active medicinal



ingredients. Any compound, mixture, or preparation containing any of



the following narcotic drugs, or their salts calculated as the free



anhydrous base or alkaloid, in limited quantities as set forth below,



which shall include one or more nonnarcotic active medicinal



ingredients in sufficient proportion to confer upon the compound,



mixture, or preparation valuable medicinal qualities other than those



possessed by narcotic drugs alone:



   (1) Not more than 200 milligrams of codeine per 100 milliliters or



per 100 grams.



   (2) Not more than 100 milligrams of dihydrocodeine per 100



milliliters or per 100 grams.



   (3) Not more than 100 milligrams of ethylmorphine per 100



milliliters or per 100 grams.



   (4) Not more than 2.5 milligrams of diphenoxylate and not less



than 25 micrograms of atropine sulfate per dosage unit.



   (5) Not more than 100 milligrams of opium per 100 milliliters or



per 100 grams.



   (6) Not more than 0.5 milligram of difenoxin and not less than 25



micrograms of atropine sulfate per dosage unit.



   (d) Buprenorphine.
Back To California Laws - Back To Your Safety


[ Recursos en Español ]
[ site map ]

Your Safety | Enforcement | Identification | Drugs & Youth | Endangered Kids
Prevention | Treatment | Links | Media | Events | The Fight